Neurogenetics

Aims & Scope

Neurogenetics publishes findings that contribute to a better understanding of the genetic basis of normal and abnormal function of the nervous system.

Neurogenetic disorders are the main focus of the journal.

Neurogenetics therefore includes findings in humans and other organisms that help understand neurological disease mechanisms and publishes papers from many different fields such as biophysics, cell biology, human genetics, neuroanatomy, neurochemistry, neurology, neuropathology, neurosurgery and psychiatry.

All papers submitted to Neurogenetics should be of sufficient immediate importance to justify urgent publication.

They should present new scientific results.

Data merely confirming previously published findings are not acceptable.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.2
2024	1.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.676

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	70

Journal Rank

Year	Value
2024	8462

Journal Citation Indicator

Year	Value
2024	180

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Gene expression analyses reveal molecular relationships among 20 regions of the human CNS

  Citation: 295

  Authors: Richard B., Peter, Jerry, Dorian, Sandra M., Alan C., Albert

• Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses

  Citation: 253

  Authors: Sara E., Ruth E., Hans H.

• Heterogeneous dysregulation of microRNAs across the autism spectrum

  Citation: 230

  Authors: Kawther, Tsunglin, Francesca S., Yuhei, Dennis P., Daniel H., Kaiqin, Kenneth S.

• PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2

  Citation: 229

  Authors: Ken

• A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan

  Citation: 199

  Authors: Alessio, Yah-Huei, Chin-Song, Marina, Erik J., Christan F., Hsiu-Chen, Rou-Shayn, Yi-Hsin, Nicola, Guido J., Ben A., Vincenzo

• Lrrk2 pathogenic substitutions in Parkinson's disease

  Citation: 199

  Authors: Ignacio F., Jennifer M., Julie P., Sarah, Jan, Timothy, Mary M., Stephanie A., Ruey-Meei, Chin-Song, Carlos, Zbigniew K., Matthew J.

• Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease

  Citation: 197

  Authors: L. B., D. C., M., D. T., R. K. B., M. B.

• Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management

  Citation: 153

  Authors: M., M., B., V., D., G., E., C., S., N., M., J. P., D., C., M.

• CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations

  Citation: 143

  Authors: Katrin, Sonja, Elisa, Sybille, Joachim, Thomas D., Ute

• Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism

  Citation: 142

  Authors: Joanne, Christine, Jennifer, Peter, Helfried, Dana, Christoph, Deborah, Peter P., John B., Marvin, Joseph, Thomas, Susan B., David P., Patricia, Mitchell F., Laurie J., Xandra O.

---